logo
Select company
Select metric
$ -3.01EBIT per Share
VS
Market
10
Sector
23
Industry
29
History
48
$ 26.83Close
$ 15.13 - $ 28.76 52-Week Range
Ticker Information

Ticker

CLDX

Company Name

CELLDEX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CELLDEX THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CLDX - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -199.61M$ -3.01166.39M
3/31/2025$ -178.85M$ -2.69166.38M
12/31/2024$ -157.86M$ -2.45164.39M
9/30/2024$ -154.08M$ -2.32166.29M
6/30/2024$ -150.22M$ -2.28166.02M
3/31/2024$ -144.88M$ -2.46158.87M
12/31/2023$ -141.43M$ -2.92148.45M
9/30/2023$ -124.61M$ -2.64147.26M
6/30/2023$ -113.13M$ -2.39147.25M
3/31/2023$ -118.64M$ -2.51147.21M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CELLDEX THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -1.24.
  • Over the past 5 years, CELLDEX THERAPEUTICS INC's average EBITPS has been $ -2.2.
  • The median EBITPS for CELLDEX THERAPEUTICS INC during this period was $ -2.3
  • CELLDEX THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -1.24.
  • The lowest EBITPS recorded by CELLDEX THERAPEUTICS INC in the same timeframe $ -3.01

CELLDEX THERAPEUTICS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
LENZ : LENZ THERAPEUTICS INC $ -1.85PRAX : PRAXIS PRECISION MEDICINES INC $ -11.69IDYA : IDEAYA BIOSCIENCES INC $ -3.75DNTH : DIANTHUS THERAPEUTICS INC $ -3.2PRME : PRIME MEDICINE INC $ -1.54TSHA : TAYSHA GENE THERAPIES INC $ -0.31PGEN : PRECIGEN INC $ -0.42UPB : UPSTREAM BIO INC $ -1.94VRDN : VIRIDIAN THERAPEUTICS INC $ -4.18JANX : JANUX THERAPEUTICS INC $ -1.71

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for CELLDEX THERAPEUTICS INC is calculated as follows: EBIT [ $ -48.55M ] / (Shares WA [ 39.28M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -1.24 ]

CLDX - EBIT per Share, Last 5 years

$ -3.01

Minimum

Jun 30, 2025

$ -1.24

Maximum

Sep 30, 2020

$ -2.2

Average

$ -2.3

Median

EBITPS Benchmark Analysis

The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.41.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.71
max$ 10.76
average$ 1.16
median$ 0.39
std$ 3.41